AGN: Allergan plc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 63,364.03
Enterprise Value ($M) 89,999.12
Book Value ($M) 61,542.00
Book Value / Share 187.74
Price / Book 1.03
NCAV ($M) -30,187.40
NCAV / Share -92.09
Price / NCAV -2.10

Profitability (mra)
Return on Invested Capital (ROIC) -0.06
Return on Assets (ROA) -0.04
Return on Equity (ROE) -0.07

Liquidity (mrq)
Quick Ratio 0.60
Current Ratio 0.71

Balance Sheet (mrq) ($M)
Current Assets 6,289.30
Assets 98,036.30
Liabilities 36,476.70
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -6,247.60
Net Income -5,086.20
Earnings Per Share Diluted -15.26
Earnings Per Share Basic -15.26

Cash Flow Statement (mra) ($M)
Cash From Operations 5,640.10
Cash from Investing 3,098.50
Cash from Financing 3,098.50

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-06-01 13D/A Cf Partners Capital Management Llp 1.34 -74.15
2020-02-12 13G/A Vanguard Group Inc 7.46 1.35
2020-02-10 13G/A BlackRock Inc. 6.30 -3.07
2019-02-12 13G/A Wellington Management Group LLP 7.39 15.98
2019-01-22 13G/A GIC Private Ltd 4.59 -9.18
2018-02-08 13G/A Goldman Sachs Group Inc 0.70 -89.64
2017-02-06 13G/A Price T Rowe Associates Inc /md/ 2.80 -58.06
2016-02-12 13G/A FMR LLC / Fidelity 4.17
2015-03-23 13D/A Pershing Square Capital Management, L.P. 0.00
2015-02-13 13G/A Capital Research Global Investors 0.00
2014-11-20 13D/A Valeant Pharmaceuticals International, Inc. 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2020-05-07 10-Q Allergan’s unaudited consolidated financial statements as of March 31, 2020 and for the three months ended March 31, 2020 and March 31, 2019 and the related notes, included in Allergan’s Quarterly Report on Form 10-Q (File No. 001-36867) for the quarter ended March 31, 2020, as filed with the SEC on May 7, 2020.
2020-05-07 10-Q Quarterly Report – 10-Q
2020-04-29 10-K/A Annual Report – 10-K/A
2020-04-29 10-K/A Annual Report – 10-K/A
2020-02-18 10-K AGN / Allergan plc 10-K – Annual Report – 10-K
2020-02-18 10-K AGN / Allergan plc 10-K – Annual Report – 10-K
2019-11-05 10-Q AGN / Allergan plc 10-Q – Quarterly Report – 10-Q
2019-11-05 10-Q AGN / Allergan plc 10-Q – Quarterly Report – 10-Q
2019-08-08 10-Q AGN / Allergan plc 10-Q – Quarterly Report – 10-Q
2019-08-08 10-Q August 8, 2019

(click for more detail)

Similar Companies
ABBV – AbbVie Inc. ABT – Abbott Laboratories
ALR – Alere Inc. BHS – Bausch Health Companies


Financial data and stock pages provided by
Fintel.io